Internal Server Error

About Paladin Capital

Paladin Capital is a venture capital firm founded in 2001. It is primarily based out of Washington, DC, United States. As of Feb 2026, Paladin Capital is an active investor, having invested in 114 companies, with 5 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Enterprise Infrastructure. Most recently it participated in the $***** Seed round of Stanhope AI Overall, Paladin Capital portfolio has seen 4 unicorns, 6 IPOs and 43 acquisitions including key companies like 10X Genomics, Twist Bioscience and NiCE. A lot of funds co-invest with Paladin Capital, with names like Vertical Venture Partners sharing a substantial percentage of its portfolio. Paladin Capital has team of 44 people including 16 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Series A, Seed & 7 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Paladin Capital's List of Top Investments

Paladin Capital has a portfolio of 114 companies, including 4 unicorns. Their most notable investments are in Secure Code Warrior and SCYTHE.Their portfolio spans across United States, United Kingdom, Australia and 11 more locations. They have invested in Enterprise Applications, High Tech, Enterprise Infrastructure and 24 other sectors, across stages such as Series A, Seed  and 7 more. Here is the list of top investments by Paladin Capital:
Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis. The company develops instruments, consumables, and software that enable researchers to profile up to a million cells, map RNA and proteins in tissues, and support multiomics workflows, with products cited in publications.

Key facts about 10X Genomics

  • Founded Year: 2012
  • Location: Pleasanton (United States)
  • Annual Revenue: $500M - $1B as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $243M
  • Employee Count: 2,429 as on Jul 31, 2026
  • Investors: Sprout Capital Partners, Meritech and 14 Others
  • Latest Funding Round: Series D, Jan 07, 2019, $*****
  • Highlight: Public
Provider of secure code learning platform for software development teams. The platform offers hands-on missions and contextual tools for developers to build secure software. It delivers resources for self-paced learning, customized curriculums, skills assessments, and coding tournaments. The platform helps development teams measure and improve their security framework.

Key facts about Secure Code Warrior

Developer of a semiconductor-based DNA synthesis platform. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA which is used in diverse fields of medicine, agriculture, industrial chemicals and data storage. It offers synthetic genes, oligo pools, and NGS target enrichment to support research and innovation

Key facts about Twist Bioscience

4. NiCE

Developer of platforms automating customer service using artificial intelligence. This technology streamlines engagements into automated actions across multiple channels including voice and digital platforms. The system supports contact centers by providing workforce management, interaction analytics, and predictive outreach tools. These features assist organizations in handling interactions from intent to final resolution. The platform integrates with existing business systems to provide operational insights, quality monitoring, and compliance controls. Organizations utilize these tools to manage performance across both human agents and automated artificial intelligence agents. The service provides global connectivity with built-in redundancy for continuous operation. Business users access these capabilities through a unified cloud interface to manage workflows, monitor agent performance, and improve productivity.

Key facts about NiCE

Provider of blockchain analytics software for digital asset risk management. This technology enables the screening of transactions and wallets to identify potential financial crime. It facilitates the monitoring of digital asset activity to detect illicit behavior and assess risk levels associated with stablecoin issuers and decentralized finance protocols. The software provides tools for forensic investigations, allowing for the tracing of funds across different blockchain networks. It also offers data integration capabilities to support compliance workflows and regulatory reporting requirements.

Key facts about Elliptic

  • Founded Year: 2013
  • Location: London (United Kingdom)
  • Annual Revenue: £10M - £50M as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series D
  • Total Funding till date: $224M
  • Employee Count: 260 as on Jul 31, 2026
  • Investors: Nasdaq, SoftBank Vision Fund and 36 Others
  • Latest Funding Round: Series D, Jul 11, 2026, $*****
  • Highlight: Editors' Pick

Paladin Capital's Investments by Stage

Paladin Capital has made 44 investments in Series A stage with an average round size of $13M, 21 investments in Seed stage with an average round size of $4.67M and 19 investments in Series B stage with an average round size of $23.1M.
Here are Paladin Capital's investments by stage:
Stage of entry
No. of Investments
Series A
44
Seed
21
Series B
19
Series C
9
Series D
3
Others
6
Breakdown of Paladin Capital's investments by stage of entrySeries A (44)Seed (21)
Note: We have considered here, only first round of investments

Paladin Capital's Investments by Sector

Paladin Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Enterprise Infrastructure, High Tech, Life Sciences and FinTech. Notably, it has invested in 99 Enterprise (B2B) companies, 89 Tech companies, 79 Software companies and at least 48 companies focusing on Saas.
Here are Paladin Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
69
Enterprise Infrastructure
47
High Tech
22
Life Sciences
10
FinTech
9
Others
55
Breakdown of Paladin Capital's investments by sectorsEnterprise Applic... (69)Enterprise Infras... (47)
Note: We have considered here, only first round of investments

Paladin Capital's Investments by Geography

Paladin Capital has made most investments in United States (75), followed by United Kingdom where it has made 11 investments.
Here are Paladin Capital's investments by geography:
Country
No. of Investments
United States
75
United Kingdom
11
Australia
3
Germany
2
Israel
2
Others
9
Breakdown of Paladin Capital's investments by countriesUnited States (75)United Kingdom (11)
Note: We have considered here, only first round of investments

Paladin Capital's recent investments

Paladin Capital has made 3 investments in 2026 so far. Stanhope AI and Arpio are the latest among them.
Here are the most recent investments by Paladin Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Feb 12, 2026
United Kingdom
Seed
9581
Feb 04, 2026
United States
Series A
4551
Jan 20, 2026
United States
Seed
3064
-
Nov 18, 2025
United States
Seed
8703
Nov 06, 2025
United States
Series A
5512

Unicorns in Paladin Capital's Portfolio

Paladin Capital has 4 unicorns in its portfolio - SandboxAQ, Semperis, Bugcrowd and others. The most recent unicorn in their portfolio is SandboxAQ. It became a unicorn in 2024, 2 years after Paladin Capital first invested in it.
Here is a list of unicorns in Paladin Capital's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
64
Developer of quantitative artificial intelligence models for various industry applications
2022
Palo Alto
Series E
yllcxk{
66
Provider of Active Directory and Entra ID security and recovery solutions
2013
Hoboken
Series C
asjhwaz
66
Provider of crowdsourced security platform offering vulnerability disclosure and penetration testing
2012
San Francisco
Series E
ezrfv{k
59
Managed detection and response provider
2016
Herndon
Series E
uwe{bvs

IPOs and Publicly Listed companies in Paladin Capital's Portfolio

6 of Paladin Capital's portfolio companies have become public. Royalty Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2020 and 10X Genomics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $3.66B.
Here are Paladin Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 16, 2020
-
-
3781
Sep 12, 2019
Mar 12, 2015
Series B
2755
Oct 31, 2018
Feb 07, 2014
Series A
8326
Dec 17, 2015
Dec 21, 2012
Series A
5999
Feb 19, 2002
-
-
5261

Acquired companies in Paladin Capital's Portfolio

43 companies from Paladin Capital's portfolio have been acquired. The most recent acquisition was IriusRisk in Jan 2026 by ThreatModeler for $*****.
Here are Paladin Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jan 08, 2026
Sep 30, 2020
Series A
5819
Oct 28, 2025
Jan 25, 2019
Seed
1745
Sep 23, 2025
May 22, 2019
Seed
8620
Sep 11, 2025
Jul 22, 2020
Series A
4833
Jul 01, 2025
-
-
1850

Team profile of Paladin Capital

Paladin Capital has a team of 44 members including 16 Partners, 3 Venture Partners and 5 Principals located in United States and United Kingdom. Paladin Capital's team sits on the board of 3 companies.
Here is a list of top team members in Paladin Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Washington
-
Partner
Arlington
-
-
Partner
Washington
-
Partner
United States
-
Partner
Los Angeles
-
Partner
United States
-
Partner
London
Partner
United Kingdom
-
-
Partner
United States
-
Partner
United States
-

Co-investors of Paladin Capital

Over the past 26 years, 554 investors have co-invested in Paladin Capital's portfolio companies. This includes funds and angels.

  • Invested before Paladin CapitalDFJ, YL Ventures and 136 others have invested in rounds before Paladin Capital. There are 2 companies where DFJ has invested before Paladin Capital and 2 companies where YL Ventures has invested before Paladin Capital.
  • Top Co-investors of Paladin Capital217 investors entered a company along with Paladin Capital. These include investors like Vertical Venture Partners (4 companies).
  • Invested after Paladin CapitalA total of 199 investors have invested in Paladin Capital's portfolio after their investments. Top Investors include SVB (5 companies), Cisco Investments (5 companies) and Fidelity Investments (4 companies).

Recent News related to Paladin Capital

View all news related to Paladin Capital

FAQs about Paladin Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford